Variant report
Variant | nsv977167 |
---|---|
Chromosome Location | chr13:37498073-37499916 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:4 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr13:37498376-37498389 | Fibrobl | skin: | n/a | n/a |
2 | POLR2A | chr13:37498370-37498450 | Gliobla | brain: | n/a | n/a |
3 | SPI1 | chr13:37499856-37500081 | GM12878 | blood: | n/a | n/a |
4 | SPI1 | chr13:37499756-37500031 | GM12891 | blood: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:37492680..37494587-chr13:37496593..37498189,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SMAD9 | TF binding region |
ENSG00000120693 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs577651031 | chr13:37498114-37498115 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs187076795 | chr13:37498127-37498128 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs375919721 | chr13:37498138-37498139 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs112187209 | chr13:37498185-37498186 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs538956406 | chr13:37498226-37498227 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557187049 | chr13:37498227-37498228 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs532728883 | chr13:37498228-37498229 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs73535800 | chr13:37498235-37498236 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs536428337 | chr13:37498247-37498248 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs151076406 | chr13:37498283-37498284 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs535007061 | chr13:37498305-37498306 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs374269857 | chr13:37498306-37498307 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs573278027 | chr13:37498310-37498311 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs540687214 | chr13:37498314-37498315 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs112921497 | chr13:37498378-37498379 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs191551342 | chr13:37498383-37498384 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs550835098 | chr13:37498389-37498390 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs17054718 | chr13:37498410-37498411 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs369580227 | chr13:37498422-37498423 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs542417003 | chr13:37498436-37498437 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs562760684 | chr13:37498454-37498455 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs515397 | chr13:37498469-37498470 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
23 | rs541639201 | chr13:37498533-37498534 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs531404736 | chr13:37498569-37498570 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs527414071 | chr13:37498589-37498590 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs552209213 | chr13:37498637-37498638 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs570117450 | chr13:37498645-37498646 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs34525095 | chr13:37498659-37498660 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs550904462 | chr13:37498663-37498664 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs569185277 | chr13:37498666-37498667 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs553472098 | chr13:37498690-37498691 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536923280 | chr13:37498711-37498712 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs548512941 | chr13:37498714-37498715 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs567013380 | chr13:37498723-37498724 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs534034476 | chr13:37498747-37498748 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs564856608 | chr13:37498749-37498750 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs184424331 | chr13:37498766-37498767 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs577349622 | chr13:37498767-37498768 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs138793127 | chr13:37498781-37498782 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs556528274 | chr13:37498791-37498792 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574667572 | chr13:37498801-37498802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs9576139 | chr13:37498944-37498945 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs142917136 | chr13:37498973-37498974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs572159866 | chr13:37499012-37499013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs150363945 | chr13:37499059-37499060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs199762501 | chr13:37499078-37499079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs398117208 | chr13:37499090-37499091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs545627068 | chr13:37499109-37499110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs137916314 | chr13:37499115-37499116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs1547676 | chr13:37499143-37499144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17899364 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Trisomy | 24170809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Alveolar rhabdomyosarcoma | 16790082 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Prostate cancer | 21965145 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Monoclonal gammopathy of undetermined significance | 19135901 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Melanoma | 18172304 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:37495600-37500000 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
2 | chr13:37496800-37498400 | Weak transcription | HepG2 | liver |
3 | chr13:37498200-37498400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr13:37498400-37498800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr13:37498400-37498800 | Enhancers | HepG2 | liver |
6 | chr13:37498800-37499800 | Weak transcription | HepG2 | liver |
7 | chr13:37499800-37500000 | Enhancers | HepG2 | liver |